Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF)
- 1 May 1994
- journal article
- Published by Elsevier in Brain Research
- Vol. 647 (1) , 30-36
- https://doi.org/10.1016/0006-8993(94)91395-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Development of mRNAs for glucocorticoid and mineralocorticoid receptors in rat hippocampusDevelopmental Brain Research, 1994
- Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesionsNeuroReport, 1993
- Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivoNeuron, 1993
- Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brainJournal of Neuroscience, 1992
- The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatumBrain Research, 1991
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991
- Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culturePublished by Elsevier ,1990
- pl Bl5: A cDNA Clone of the Rat mRNA Encoding CyclophilinDNA, 1988
- Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cellsJournal of Neuroscience, 1986
- Thy-1 antigen: A ganglion cell specific marker in rodent retinaNeuroscience, 1984